Resolution Therapeutics is a biotechnology company developing macrophage cell therapy to treat inflammatory organ disease. The company was founded following a productive collaboration between Edinburgh’s Centre for Regenerative Medicine, the Scottish National Blood Transfusion Service, and Syncona Investment Management Limited.
Resolution Therapeutics’ multidisciplinary team brings together a diverse set of skills to pursue their mission. Their initial focus is chronic liver disease. Resolution Therapeutics (RTx) are developing a macrophage cell therapy product to treat patients at risk of liver decompensation, thus helping them avoid the need for a liver transplant.
RTx approached Bulb for assistance in expanding their laboratories premises and associated office.
We also helped Resolution Therapeutics in the design and delivery of a brand new office space, click below to see the results.
Skills & Results
The creation of additional laboratory premises in existing CAT A office space, to include five CL2 laboratories, open plan office space, three meeting rooms, breakout area, tea point area and telephone booths.
To accommodate the supplementary ventilation, a new on floor plant room was created to house the air handling unit & provide gas storage. On receipt of planning consent, windows were removed to install louvres & provide the supply air & extraction from the plant room. A new air conditioning system was then installed throughout the laboratory area.
The laboratory fit out included Cat 5 water, small power & data distribution, part glazed partitions & new laboratory furniture. The office areas provided with new carpets, furniture & feature lighting.